Corticosteroid treatment of experimental autoimmune encephalomyelitis in the Lewis rat results in loss of Vβ8.2+ and myelin basic protein-reactive cells from the spinal cord, with increased total T-cell apoptosis but reduced apoptosis of Vβ8.2+ cells

This publication has 25 references indexed in Scilit:

• Apoptosis of Vβ8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein
  Journal of the Neurological Sciences, 1996
• Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system
  International Immunology, 1995
• Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids.
  The Journal of Experimental Medicine, 1995
• Apoptotic elimination of Vβ8.2⁺ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8.2⁺ encephalitogenic T cells
  European Journal of Immunology, 1994
• The anti-inflammatory activity of glucocorticoids
  Molecular Biology Reports, 1994
• Preferential distribution of Vβ 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis
  European Journal of Immunology, 1993
• Apoptosis of αβ T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: Its possible implications for recovery and acquired tolerance
  Journal of Autoimmunity, 1992
• Evaluation of glucocorticoid‐induced DNA fragmentation in mouse thymocytes by flow cytometry
  Cell Proliferation, 1991
• Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids.
  The Journal of Experimental Medicine, 1989
• LARGE DOSE CORTICOSTEROID THERAPY OF EXPERIMENTAL AND HUMAN DEMYELINATING DISEASES^*
  Annals of the New York Academy of Sciences, 1965